| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.52 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.58 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |